GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Invitro International (OTCPK:IVRO) » Definitions » EV-to-FCF

Invitro International (Invitro International) EV-to-FCF : -1.77 (As of Jun. 07, 2024)


View and export this data going back to 1991. Start your Free Trial

What is Invitro International EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Invitro International's Enterprise Value is $1.57 Mil. Invitro International's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2097 was $-0.89 Mil. Therefore, Invitro International's EV-to-FCF for today is -1.77.

The historical rank and industry rank for Invitro International's EV-to-FCF or its related term are showing as below:

IVRO's EV-to-FCF is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 25.22
* Ranked among companies with meaningful EV-to-FCF only.

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-07), Invitro International's stock price is $0.0778. Invitro International's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2097 was $-0.120. Therefore, Invitro International's PE Ratio for today is At Loss.


Invitro International EV-to-FCF Historical Data

The historical data trend for Invitro International's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invitro International EV-to-FCF Chart

Invitro International Annual Data
Trend Feb90 Feb91 Sep92 Sep93 Sep94 Sep95 Sep96
EV-to-FCF
Get a 7-Day Free Trial -1.45 -39.15 -6.80 -5.98 -3.27

Invitro International Quarterly Data
Sep92 Dec92 Mar93 Jun93 Sep93 Dec93 Mar94 Jun94 Sep94 Dec94 Mar95 Jun95 Sep95 Dec95 Mar96 Jun96 Sep96 Dec96 Mar97 Jun97
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Invitro International's EV-to-FCF

For the Diagnostics & Research subindustry, Invitro International's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Invitro International's EV-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Invitro International's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Invitro International's EV-to-FCF falls into.



Invitro International EV-to-FCF Calculation

Invitro International's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=1.572/-0.886
=-1.77

Invitro International's current Enterprise Value is $1.57 Mil.
Invitro International's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2097 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.89 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Invitro International  (OTCPK:IVRO) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Invitro International's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0778/-0.120
=At Loss

Invitro International's share price for today is $0.0778.
Invitro International's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2097 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.120.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Invitro International EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Invitro International's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Invitro International (Invitro International) Business Description

Traded in Other Exchanges
N/A
Address
330 East Orangethorpe Avenue, Suite D, Placentia, CA, USA, 92870
Invitro International is a provider of non-animal testing methods. The company develops and commercializes test kits and laboratory services. Its testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. Its products and services include Irritection, Corrositex, and Lab Services. The company provides its products to various industries such as cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, and hazardous waste transportation. The majority of its revenue is generated from the United States and it also exports to other countries.